Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC72791 structure
    GC72791Delmitide acetate
    CAS: 501019-16-5
    纯度: >98.00%

    Delmitide acetate是一种口服活性d-异构体十肽,具有强效抗炎活性。

  • GC72792 structure
    GC72792Cyclopentenylcytosine
    CAS: 90597-22-1
    纯度: >99.00%

    Cyclopentenylcytosine(CPC)是一种核苷类似物,通过抑制CTP合成酶来降低白血病细胞中胞苷三磷酸(CTP)和脱氧胞苷三磷酸盐(dCTP)的水平。

  • GC72803 structure
    GC72803Aspidin BB
    CAS: 584-28-1
    纯度: >98.00%

    Aspidin BB是一种间苯三酚衍生物,可从冠毛鳞毛蕨的地上部分分离得到。

  • GC72817 structure
    GC72817BAI1 hydrochloride
    CAS: 329349-20-4
    纯度: >99.00%

    BAI1 hydrochloride是一种选择性凋亡因子BAX变构抑制剂。

  • GC72824 structure
    GC72824KX2-361
    CAS: 897016-26-1
    纯度: >99.00%

    KX2-361(KX-02)是一种Src激酶和微管蛋白聚合抑制剂。

  • GC72835 structure
    GC72835NSC260594
    CAS: 906718-66-9
    纯度: >96.00%

    NSC260594诱导细胞凋亡。

  • GC72851 structure
    GC72851Belapectin
    CAS: 1980787-47-0
    纯度: >99.00%

    Belapectin (GR-MD-02)是半乳糖凝集素-3 (Gal-3)抑制剂。

  • GC72858 structure
    GC72858Avenanthramide A
    CAS: 108605-70-5
    纯度: >99.00%

    Avenanthramide A是一种可以在燕麦(Avena sativa L)。

  • GC72862 structure
    GC72862Erasin
    纯度: >96.00%

    Erasin是一种强效的厄洛替尼抗性拮抗STAT3抑制剂,对STAT3和STAT1的IC50分别为9.7和24μM。

  • GC72863 structure
    GC72863PZ703b TFA
    纯度: >98.00%

    PZ703b TFA是一种Bcl-xl PROTAC降解剂,诱导细胞凋亡,抑制癌细胞增殖,用于膀胱癌研究。

  • GC72864 structure
    GC72864PZ703b hydrochloride
    纯度: >99.00%

    PZ703b hydrochloride是一种Bcl-xl PROTAC降解剂,可诱导细胞凋亡,抑制癌细胞增殖。

  • GC72868 structure
    GC72868AZA197
    CAS: 1249398-09-1
    纯度: >98.00%

    AZA197是Cdc42的选择性小分子抑制剂。

  • GC72875 structure
    GC72875Justicidin A
    CAS: 25001-57-4
    纯度: >99.00%

    Justicidin A是一种天然产物,可以从Justicia procumbens中分离出来。

  • GC72878 structure
    GC72878UCD38B hydrochloride
    CAS: 1115177-19-9
    纯度: >99.00%

    UCD38B hydrochloride是一种细胞渗透的竞争性酶促uPA抑制剂,IC50值为7 μM。

  • GC72892 structure
    GC72892Oblimersen sodium
    纯度: >98.00%

    Oblimersen sodium是一种针对BCL-2 RNA的BCL-2抑制剂。

  • GC72910 structure
    GC72910DD1
    CAS: 187585-11-1
    纯度: >99.00%

    DD1蛋白酶体抑制剂,靶向急性髓系白血病(AML)凋亡过程中Bax的激活和P70S6K的降解。

  • GC72915 structure
    GC72915(R)-MRT199665
    纯度: >98.00%

    (R)-MRT199665是MRT199665的异构体。

  • GC72924 structure
    GC72924PD173952
    CAS: 305820-75-1
    纯度: >99.00%

    PD173952是一种酪氨酸激酶抑制剂,对Lyn、Abl和Csk的ic50分别为0.3、1.7和6.6 nM。

  • GC72928 structure
    GC72928DB818
    CAS: 790241-43-9
    纯度: >98.00%

    DB818是homobox A9 (HOXA9)的有效抑制剂。

  • GC72929 structure
    GC72929DB818 dihydrochloride
    纯度: 不显示

    DB818 dihydrochloride是DB818的二氯盐形式。

  • GC72931 structure
    GC72931HTH-01-091 TFA
    纯度: >98.00%

    HTH-01-091 TFA是一种有效的、选择性的母胚亮氨酸拉链激酶(MELK)抑制剂,IC50为10.5 nM。

  • GC72933 structure
    GC72933LQZ-7F
    CAS: 354543-09-2
    纯度: >97.00%

    LQZ-7F是一种survivin二聚化抑制剂,在前列腺癌细胞中诱导自发凋亡并与多西他赛协同作用。

  • GC72944 structure
    GC72944MMRi64
    CAS: 430458-66-5
    纯度: >98.00%

    MMRi64破坏Mdm2-MdmX相互作用。

  • GC72971 structure
    GC72971INCB3619
    CAS: 791826-72-7
    纯度: >99.00%

    INCB3619ADAM10和ADAM17的IC50分别为22nM和14nM。